Gene expression test identifies prostate cancer patients who benefit from hormone the

[News]

A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate cancer will benefit from adding hormone therapy to radiation after surgery - the first predictive biomarker in this setting.

More... (https://www.news-medical.net/news/20250929/Gene-expression-test-identifies-prostate-cancer-patients-who-benefit-from-hormone-therapy.aspx)